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Purpose: Ultraviolet (UV) acts as low-dose ionizing radiation. Acute UVB exposure causes photokeratitis and induces
apoptosis in corneal cells. Astaxanthin (AST) is a carotenoid, present in seafood, that has potential clinical applications
due to its high antioxidant activity. In the present study, we examined whether topical administration of AST has preventive
and therapeutic effects on UV-photokeratitis in mice.
Methods: C57BL/6 mice were administered with AST diluted in polyethylene glycol (PEG) in instillation form (15 μl)
to the right eye. Left eyes were given vehicle alone as controls. Immediately after the instillation, the mice, under
anesthesia, were irradiated with UVB at a dose of 400 mJ/cm2. Eyeballs were collected 24 h after irradiation and stained
with H&E and TUNEL. In an in vitro study, mouse corneal epithelial (TKE2) cells were cultured with AST before UV
exposure to quantify the UV-derived cytotoxicity.
Results:  UVB  exposure  induced  cell  death  and  thinning  of  the  corneal  epithelium.  However,  the  epithelium  was
morphologically well preserved after irradiation in AST-treated corneas. Irradiated corneal epithelium was significantly
thicker in eyes treated with AST eye drops, compared to those treated with vehicles (p<0.01), in a doses dependent manner.
Significantly fewer apoptotic cells were observed in AST-treated eyes than controls after irradiation (p<0.01). AST also
reduced oxidative stress in irradiated corneas. The in vitro study showed less cytotoxicity of TKE2 cells in AST-treated
cultures after UVB-irradiation (p<0.01). The cytoprotective effect increased with the dose of AST.
Conclusions: Topical AST administration may be a candidate treatment to limit the damages by UV irradiation with wide
clinical applications.
Ultraviolet  (UV)  irradiation  represents  a  significant
environmental  hazard  that  can  cause  acute  and  chronic
inflammatory changes in the cornea, lens, and retina of the
eye. The sources of UV radiation are not merely from electric
welding and tanning lamps but also from sunny days on the
sea or in snowy mountains when eyes are left unprotected. In
recent decades, the risk of acute photochemically-induced
ocular  damage  has  increased  due  to  stratospheric  ozone
depletion [1]. UVB exposure causes photokeratitis, which is
associated  with  expression  of  nuclear  factor  (NF)-κB,
prostaglandin  E2  (PGE2),  and  many  other  inflammatory
agents [1]. Acute UVB exposure causes damage deeper than
the epithelium, involving all tissues of the cornea [2] and
inducing apoptosis in corneal cells [3,4]. Although the energy
is much less than that of the gamma rays, ophthalmologists
find it is necessary to study ways to prevent the damages
caused by UV radiation due to its association with clinical
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ocular diseases. We have already reported that applying UVB
irradiation at 400 mJ/cm2 to mice corneas can be a useful
model for studying corneal inflammation [3].
Antioxidant  enzymes,  such  as  superoxide  dismutase
[5] and catalase [6], and pharmacologic antioxidants like N-
acetyl cysteine [7,8], inhibit tumor necrosis factor (TNF)-α
activation  through  NF-κB-dependent  gene  expression  [9].
Astaxanthin  (AST),  3,30-dihydroxy-b,b-carotene-4,40-
dione, a carotenoid without vitamin A activity [10,11], has
potential clinical applications due to its antioxidant activity,
which is higher than β-carotene and α-tocopherol [10,12,13].
In  addition,  it  has  many  highly  potent  pharmacological
effects, including anti-tumor, anti-cancer, anti-diabetic, and
anti-inflammation activities [12,14-16]. The potent activity of
AST  has  been  observed  to  modulate  biologic  functions
ranging from lipid peroxidation to tissue protection [14,17].
The presence of the hydroxyl (OH) and keto (C=O) on each
ionone ring in AST explains its unique feature of antioxidant
activity  for  the  protection  of  both  the  inner  and  outer
membrane surfaces [10,14,18,19]. AST is found abundantly
in the red-orange pigment of marine animals such as salmon
(and  salmon  roe)  and  the  shell  of  crabs  and  shrimp.
AST  and  AST-like  products  are  commonly  indicated  as
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455antioxidants [20] and immune modulators [21]. One of the
effects of AST is to scavenge reactive oxygen species [22].
We previously reported that AST showed a dose-dependent
anti-inflammatory  effect  [23,24].  It  was  also  reported
that AST inhibited the production of inflammatory mediators
by blocking NF-κB activation in vitro [4]. In the present study,
we  examined  whether  topical  administration  of  AST  has
therapeutic effects on UV photokeratitis in mice.
METHODS
Animals and reagents: Six- to 8-week-old C57BL/6 male
mice were obtained from Clear Japan (Tokyo, Japan). Mice
were maintained under specific pathogen-free conditions. All
procedures involving animals were performed in accordance
with the ARVO resolution on the use of animals in research.
AST was purchased from Sigma-Aldrich (Tokyo, Japan).
UV  irradiation:  The  mice  were  administered  with  AST
diluted  in  polyethylene  glycol  (PEG)  in  instillation  form
(15 μl) to the right eye once at the following concentrations:
1, 0.1, and 0.01 mg/ml (10 mice per group. Left eyes were
instilled with vehicle alone. Immediately after the instillation,
anesthetized mice were irradiated with UVB at a dose of
400  mJ/cm2  from  a  FS-20  (Panasonic,  Osaka,  Japan)
fluorescent lamp. These bulbs have a broad emission spectrum
(250–400  nm)  with  high  output  primarily  in  the  UVB
spectrum (290–320 nm). To evaluate the effects of AST on
the  corneal  surface  without  UVB  damage,  control  mice
received  the  instillation  of  1  mg/ml  of  AST  without
irradiation. All experiments were performed in triplicate.
H&E and TUNEL staining: The eyes were dissected from
mice  24  h  after  UVB  exposure  and  fixed  with  4%
paraformalin. Tissue sections were prepared and stained with
hematoxylin-eosin (H&E) for morphological analysis. Other
sections  were  stained  by  terminal  deoxynucleotidyl
transferase dUTP nick end labeling (TUNEL) assay to detect
apoptotic signaling. Apoptotic cells were detected with a Cell
Death  Detection  Kit  (Roche  Diagnostics  Japan,  Tokyo)
containing all necessary reagents for staining. Slides imaging,
cell counting, and thickness evaluations were performed with
BZ-9000  fluorescence  microscope  (Keyence,  Japan)  and
software bundled with the apparatus. At least 10 sections were
used to evaluate the epithelial thickness, measurements of 10
randomly selected areas of epithelium of central cornea was
performed and averaged.
Evaluation of the “sunglasses effect” of AST: The “sunglass
effect” represents the status when protective properties of a
substance are only due to blocking the UV rather than having
a cytoprotective effect. To evaluate this effect, and whether
AST is capable of rescuing the damaged epithelia after UVB
irradiation, we performed additional experiments where mice
were first irradiated with UVB at a dose of 400 mJ/cm2 under
anesthesia. After 5 min of irradiation, the right eyes were then
instilled with AST (1 mg/ml) and the left eyes instilled with
vehicle alone.
Detection of reactive oxygen species (ROS): The eyes were
dissected from mice 24 h after UVB exposure and frozen fresh
in optimal cutting temperature (OCT) compound with liquid
nitrogen. To visualize not only oxidative signaling but also
the  tissue  structure,  4',6-diamidino-2-phenylindole  (DAPI)
dye  (blue)  was  used  to  stain  the  nuclei  of  the  cells.
Dihydroethidium (DHE; Sigma-Aldrich, St. Louis, MO), an
oxidative  fluorescent  dye,  was  used  for  the
immunohistochemical  detection  of  cytosolic  superoxide
anion (O2
-) to evaluate ROS production in corneal epithelium
tissue, as reported recently [25].
NF-κB  immunohistochemistry  staining:  The  eyes  were
dissected from mice 24 h after UVB exposure and fixed with
4%  paraformaldehyde  and  then  paraffin-embedded.  To
evaluate the NF-κB positive cells in the corneal epithelium,
slides were rehydrated and applied with a 1:50 dilution of NF-
κB P65 antibody (Santa Cruz Biotechnology, Santa Cruz, CA)
for  12  h,  washed  with  PBS  and  then  applied  with  1:100
dilution of secondary goat anti–rabbit antibody dye conjugate
(Invitrogen, Carlsbad, CA), which gives red fluorescence.
Since NF-κB is widely present in intercellular tissue, to detect
its expression in cell nuclei, we stained the section slides
with  1:100  dilution  of  YO-PRO®-1  (Invitrogen),  which
produces a green signal from the cell nuclei. NF-κB positive
(yellow) nuclei were quantified in merged images.
In vitro study: TKE2 cells were used for in vitro study. TKE2
is a murine corneal epithelium-derived progenitor cell line
[26,27]. Mouse TKE2 cells were cultured in Defined K-SFM
(Keratinocye Serum Free Medium) with L-Glutamine, Phenol
Red, and Sodium Pyruvate (Invitrogen), supplemented with
100  U/ml  of  penicillin  and  100  U/ml  of  streptomycin,
(Invitrogen).  The  cells  were  seeded  onto  24-well  plates
(5×104  cells/well)  at  37  °C  in  a  humidified  incubator
containing 5% CO2. The cells were treated with 1, 0.1, or
0.01 mg/ml AST. After 6 h of incubation, the wells were
irradiated  with  UVB  at  a  dose  of  300  mJ/cm2  at  room
temperature for 1 min. To prevent UVB radiation absorption,
the culture media were removed just before irradiation and
replaced with a thin layer of phosphate-buffered saline (PBS).
After UVB irradiation, cells were fed with fresh medium. The
LDH  (lactate  dehydrogenase)  Cytotoxicity  Detection  Kit
(Roche Applied Science, Penzberg, Germany) was used to
determine  cytotoxicity  6  h  after  UVB  exposure.  Culture
supernatants (100 μl) were collected and added to the kit’s
work solution. After 30 min incubation, the absorbance was
measured  with  an  ELISA  reader.  All  procedures  were
performed according the user manual of the kit. Analysis was
performed in triplicate. To determine the background LDH
activity  of  the  medium  and  spontaneous  LDH  release,
additional  plates  were  prepared  with  empty  medium  and
unaffected cells. The maximum LDH release was achieved by
adding 100 μl of Triton-B to the reference wells. Cytotoxicity
percentages were calculated, and Triton-B treated wells with
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456Figure 1. Morphological properties of ultraviolet (UV)-irradiated corneas. Eyes were treated with AST eye drops before UV exposure (A: 1
mg/ml, B: 0.1 mg/ml, C: 0.01 mg/ml AST). Control subjects were not irradiated with UVB (D). R: Right eyes were given various concentrations
of AST eye drops. L: Left eyes were given vehicle alone as controls. The mean values of corneal epithelial thickness are summarized (E).
Epithelia were significantly thicker in right eyes treated with 1 and 0.1 mg/ml AST compared to the left eyes, which served as controls (p<0.01).
Protective effects of AST were found to occur in a dose-dependent manner.
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457maximum  LDH  release  were  assumed  to  be  100%.  All
experiments were performed in triplicate with 5 or more wells
for each group in each experiment.
Statistical  analysis:  All  data  were  expressed  as  the  mean
±standard deviation (SD) from the respective test or control
groups of data. Statistical significances were determined by
the paired t-test and non-parametric Mann–Whitney U-test. P
values less than 0.05 were considered significant.
RESULTS
Morphological properties: We examined the morphological
properties of UVB-irradiated and control corneas using H&E
staining. At 24 h after UVB irradiation at a dose of 400 mJ/
cm2, thinning and ulceration of the corneal epithelial layer
were observed (Figure 1). The corneal epithelial thicknesses
were 25.6±2.9, 18.8±3.5, and 8.2±3.6 μm in eyes treated with
1, 0.1, and 0.01 mg/ml of AST, respectively. The mean corneal
epithelial  thickness  in  eyes  untreated  with  AST  was
8.91±5.3  μm  after  UVB-exposure.  The  mean  corneal
epithelium thickness of non-irradiated eyes was 29.6±0.5 μm.
Corneal epithelium was well preserved, and the thickness of
the epithelium remained close to normal in the right eyes
treated with 1 mg/ml of AST instillation (Figure 1A). Its
protective  effect  decreased  gradually  in  a  concentration-
dependent  manner  (Figure  1B,C).  The  corneas  of  mice
administered with AST without UVB irradiation (Figure 1D)
showed no differences from naïve corneas (Figure 1D). The
mean  values  of  the  epithelium  thickness  of  corneas  were
calculated and summarized (Figure 1E). Corneal epithelia
were significantly thicker in eyes treated with 1 and 0.1 mg/
ml  AST  eye  drops  compared  with  vehicle-treated  eyes
(p<0.01).  Irradiated  corneas  treated  with  1  mg/ml  AST
showed corneal epithelium thickness close to naïve cornea.
AST  protected  corneal  epithelium  in  a  dose-dependent
manner (Figure 1E).
We also examined the morphological properties of UVB-
irradiated and control corneas using H&E staining when AST
was applied to corneas at a concentration of 1 mg/ml 5 min
after UVB irradiation at a dose of 400 mJ/cm2. Twenty-four
hours later, the corneal epithelial thickness was 13.7±0.8 μm
(Figure 2A). The mean corneal epithelial thickness of vehicle-
given corneas was 8.7±1.1 μm after UVB-exposure (Figure
2B).  Non-irradiated  corneal  epithelium  was  21.6±0.6  μm
thick (Figure 2C). Even when AST was administered after
UVB  irradiation,  the  corneal  epithelium  was  significantly
thicker  than  in  fellow  eyes  treated  with  vehicle  (p<0.01,
Figure 2D).
TUNEL  staining:  We  compared  TUNEL  staining  in  the
corneas of AST-treated and untreated eyes of the mice 24 h
after  UV  exposure.  Few  TUNEL-positive  nuclei  were
detected in corneas of mice treated with AST at 1 and 0.1 mg/
ml compared to untreated mice after UV irradiation (Figure
Figure 2. Morphological properties of ultraviolet (UV)-irradiated corneas treated with AST after irradiation. Eyes were treated with AST eye
drops within 5 min after UVB exposure (A: 1 mg/ml, B: 0.1 mg/ml). Control subjects were not irradiated with UVB (C). The mean values of
corneal epithelial thickness are summarized (D). Epithelia were significantly thicker when treated with 1 mg/ml AST compared to fellow eyes
as controls (p<0.01). The protective effects of AST remained, even if eyes were treated after irradiation.
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458Figure 3. TUNEL labeling at irradiated corneas with and without AST-treatment. Eyes were treated with AST eye drops before UV exposure
(A: 1 mg/ml, B: 0.1 mg/ml, C: 0.01 mg/ml AST). Control subjects were not irradiated with UVB (D). R: Right eyes were given various
concentrations of AST eye drops. L: Left eyes were given vehicle alone as controls. Numbers of apoptotic corneal cells per slide after UVB
exposure is shown (E). Apoptotic cells were significantly fewer in right eye corneas treated with 1 (p<0.01), 0.1 (p<0.05), and 0.01 (p<0.05)
mg/ml AST eye drops compared to the left eyes, which served as controls. There were no apoptotic cells detected in corneas without irradiation.
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459Figure 4. Reactive oxygen species signal expression after UVB exposure. Reactive oxygen species (ROS) were strongly detected (red) in
untreated corneal epithelium after UVB irradiation (A). The ROS signal was weak in AST treated corneas (B) and close to unspecific ROS
signaling in naïve corneas (C). The mean gray values of the corneal epithelium of DHE stained slides were evaluated by Image J software
and summarized (D). Mean gray values were significantly lower in corneas treated with 1 mg/ml AST eye drops than in the vehicle-treated
eyes (p<0.05).
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460Figure 5. NF-κB expression in corneal epithelia. Eyes were given vehicle alone (A) or treated with AST eye drops before UV exposure (B);
control subjects were not irradiated with UVB (C). The mean values of NF-κB positive cells (yellow) in corneal epithelial were summarized
(D). Expression of NF-κB was significantly downregulated in AST-treated mice after UVB irradiation (p<0.05).
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4613A,B). No significant protective effect was observed in eyes
treated with AST 0.01 mg/ml (Figure 3C). There were no
apoptotic cells detected in corneas without UVB exposure
(Figure 3D).
TUNEL-positive cells were counted, and the numbers
were 1.5±3.0, 5.0±4.1, and 8.25±0.9 in eyes treated with 1,
0.1, and 0.01 mg/ml of AST, respectively (Figure 3E). The
mean number of apoptotic cells was 18.4±4.7 in vehicle-given
irradiated  corneas.  The  apoptotic  cells  were  significantly
fewer in corneas treated with AST than those with vehicle only
(p<0.01).
Detection  of  reactive  oxygen  species  (ROS):  Confocal
microscopic  images  was  examined  to  quantify  reactive
oxygen species (ROS) production in mouse corneal tissue.
ROS production was determined by conversion of DHE to
ethidium bromide (EtBr). All images were made in parallel at
identical settings (Figure 4). ROS were strongly detected in
untreated corneal epithelium after UVB irradiation (Figure
4A). However, the ROS signal was downregulated in AST-
treated  corneas  (Figure  4B)  and  close  to  unspecific  ROS
signaling in naïve corneas (Figure 4C). The mean gray values
of  the  corneal  epithelium  of  DHE  stained  slides  were
evaluated by Image J software and summarized in Figure 4D.
The mean gray value in vehicle-given irradiated corneas was
23.3±3.3. In eyes treated with 1 mg/ml of AST, after UVB
irradiation,  the  mean  gray  value  was  12.08±0.5.  Non-
irradiated corneal epithelium showed a 15.04±0.8 mean gray
value. AST-treated epithelium showed significantly (p<0.05)
lower mean gray values than irradiated corneas did.
NF-κB downregulation by AST: Previously, we reported that
AST  decreased  NF-κB  expression  in  endotoxin-induced
uveitis (EIU) and choroidal neovascularization [23,24]. To
examine  whether  AST  administration  effects  NF-κB  in
corneal  epithelium,  we  immunohistochemically  analyzed
AST expression in the collected corneal tissues and examined
it  with  confocal  microscope.  NF-κB  positive  nuclei
(yellow) were found to be 13.0±7.9 in corneal epithelial cells
in UV-irradiated mice treated with AST at 1.0 mg/kg (Figure
5A).  However,  36.0±6.2  (Figure  5B)  of  multiple  NF-
κB positive cells were found in the corneal epithelial cells in
UV-irradiated mice untreated with AST. Naïve mice corneal
tissues showed weak response to anti-NF-κB antibodies, and
only  1.3±1.1  positive  nuclei  were  found  (Figure  5C).
Expression  of  NF-κB  was  significantly  downregulated  in
AST-treated mice after UVB irradiation (p<0.05, Figure 5D).
AST  suppressed  phototoxicity  in  corneal  epithelial  cell
cultures  after  UVB  irradiation:  Next,  cytotoxicity  was
examined  in  UVB-irradiated  TKE2  cells,  murine  corneal
epithelium-derived progenitor cell line, treated or untreated
with AST in vitro (Figure 6). The percentages of cytotoxicity
after  irradiation  were  17.6±2.0,  29.5±2.2,  31.7.2±2.8,  and
32.7±1.7% in wells containing 1, 0.1, 0.01, and 0 mg/ml of
AST, respectively. Cytotoxicity was significantly suppressed
by  1  mg/ml  (p<0.01)  and  0.1  mg/ml  (p<0.05)  AST
administration. The effect was AST concentration-dependent.
DISCUSSION
The corneal epithelium serves to protect corneal structures
against UV damage by absorbing a substantial amount of UV
energy. Though the energy of UV is much less than that of
ionizing radiation rays, the injuries on cells and DNA are
critical. Excessive UVB irradiation induces various changes
of  DNA,  proteins  and  cells,  through  activation  of  pro-
inflammatory  mediators  including  NF-κB.  AST  can  form
stable resonance structures by attachment of the carbonyl and
hydroxyl groups to its β-ionone ring. It can also remove the
chain-carrying  lipid  peroxyl  radicals  in  the  liposomal
suspension, protecting cells from oxidative and free radical
damages.  NF-κB  activates  proinflammatory  cytokines,
chemokines,  and  enzymes  that  generate  mediators
of inflammation. It can also activate adhesion molecules that
play a key role in the initial recruitment of leukocytes to sites
of inflammation. Therefore, activation of NF-κB leads to a
coordinated  upregulation  of  many  genes  whose  products
mediate  the  inflammatory  loop  and  perpetuate
local  inflammatory  responses.  In  our  previous  studies,
AST inhibited the in vivo activation of NF-κB in endotoxin-
induced uveitis (EIU) and choroidal neovascularization [23,
24].  Therefore,  reactive  oxygen  species-induced  oxidative
stress may play an important role in NF-κB activation and
proinflammatory  cytokine  production.  Our
immunohistochemical finding shows that AST has the same
effects of reducing NF-κB expression in corneal epithelia. The
anti-inflammatory effects of AST, through its suppression
of NF-κB activation, may be based on its antioxidant activity,
Figure 6. UVB-induced cytotoxicity in TKE2 cells in vitro. AST was
added to a culture of UVB-irradiated TKE2 cells. Cytotoxicity after
UVB exposure in keratinocyte cultures was significantly decreased
by AST in a dose-dependent manner (1 mg/ml: p<0.01, 0.1 mg/ml:
p<0.05, and 0.01 mg/ml: not significant).
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462as  previous  reports  showed  that  several  antioxidants
efficiently  inhibit  NF-κB  activation  induced  by
lipopolysaccharides (LPS) in cell systems [28-33]. Therefore,
these effects appear to be mediated by the powerful radical
scavenger properties of the antioxidants, which apparently
counteract reactive oxygen intermediates generated by NF-
κB activation [30,34,35].
We also showed that the relieving effect of AST on UVB
photokeratitis  is  not  derived  from  light-interception
(sunglasses  effect)  but  its  direct  pharmacological  effect
(Figure 2). In fact, a previous study showed that AST eye
drops did not delay the progression of UVB-induced cataract
in rats when AST was not on lens [36]. In addition, UVB
irradiation improved AST accumulation in green microalgae
[8]. These results strongly suggest that AST can produce a
protective effect against UV, and organisms have been using
AST to save themselves from harmful UV light.
AST is found abundantly in the red-orange pigment of
marine animals such as salmon (and salmon roe) and the shells
of  crabs  and  shrimp.  Humans  have  taken  in  these  food
products since ancient times, and AST is now available as an
oral supplement. Therefore, AST may be free of any harmful
side effects. In the present study, we demonstrated that topical
AST,  instead  of  systemic  administration,  is  effective  in
protecting the ocular surface against UV exposure with no
adverse  effects.  Thus,  in  conclusion,  AST  might  be  a
promising naturally-derived substance for protecting ocular
surfaces from the damages caused by ultraviolet radiation.
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